These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16966255)

  • 1. CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease.
    Varona R; Cadenas V; Lozano M; Moreno-Ortiz MC; Kremer L; Martínez-A C; Márquez G
    Leuk Lymphoma; 2006 Aug; 47(8):1469-76. PubMed ID: 16966255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses.
    Varona R; Cadenas V; Gómez L; Martínez-A C; Márquez G
    Blood; 2005 Jul; 106(1):18-26. PubMed ID: 15774622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
    Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
    J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.
    Kleinewietfeld M; Puentes F; Borsellino G; Battistini L; Rötzschke O; Falk K
    Blood; 2005 Apr; 105(7):2877-86. PubMed ID: 15613550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of CCR6 inhibits CD4+ regulatory T-cell development and M-cell formation inside Peyer's patches.
    Lügering A; Floer M; Westphal S; Maaser C; Spahn TW; Schmidt MA; Domschke W; Williams IR; Kucharzik T
    Am J Pathol; 2005 Jun; 166(6):1647-54. PubMed ID: 15920150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.
    Haase D; Starke M; Puan KJ; Lai TS; Rotzschke O
    Immunol Res; 2012 Sep; 53(1-3):200-12. PubMed ID: 22418725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
    Xystrakis E; Bernard I; Dejean AS; Alsaati T; Druet P; Saoudi A
    Eur J Immunol; 2004 Feb; 34(2):408-17. PubMed ID: 14768045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy.
    Yakoub-Agha I; Saule P; Depil S; Micol JB; Grutzmacher C; Boulanger-Villard F; Bauters F; Jouet JP; Dessaint JP; Labalette M
    Leukemia; 2006 Sep; 20(9):1557-65. PubMed ID: 16826221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
    van der Waart AB; van der Velden WJ; van Halteren AG; Leenders MJ; Feuth T; Blijlevens NM; van der Voort R; Dolstra H
    PLoS One; 2012; 7(12):e50896. PubMed ID: 23226545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets.
    Menning A; Höpken UE; Siegmund K; Lipp M; Hamann A; Huehn J
    Eur J Immunol; 2007 Jun; 37(6):1575-83. PubMed ID: 17474155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tbet is a critical modulator of FoxP3 expression in autoimmune graft-
    Amarnath S; Laurence A; Zhu N; Cunha R; Eckhaus MA; Taylor S; Foley JE; Ghosh M; Felizardo TC; Fowler DH
    Haematologica; 2017 Aug; 102(8):1446-1456. PubMed ID: 28473623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
    Yang K; Fan ZP; Liu QF; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability.
    Lu Y; Wang X; Gu J; Lu H; Zhang F; Li X; Qian X; Wang X; Lu L
    Int Immunopharmacol; 2015 Oct; 28(2):925-30. PubMed ID: 25864618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.